ARDD is proud to have InsideTracker as a Tier 3 sponsor! In the fifth episode of the "Interviews with hashtag #ARDD2024 Sponsors" series (link in the comments), the Chief Scientific Officer Gil Blander, talks with Dominika Wilczok about: 🔴InsideTracker's approach to longevity and health optimization 🔴Motivation for sponsoring ARDD 🔴Gil's personal interest in aging research 🔴ARDD's #longevitymedicine track and its relevance to InsideTracker 🔴Upcoming research results and insights from InsideTracker's large-scale study 🔴 InsideTracker's product offerings and how customers can access them See the video here: https://lnkd.in/dJ6UkrDp Only 30 days left for #ARDD!
Aging Research & Drug Discovery Meeting
Forskning inden for bioteknologi
Welcome to the 11th annual Aging Research and Drug Discovery Meeting
Om os
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
- Websted
-
https://agingpharma.org/
Eksternt link til Aging Research & Drug Discovery Meeting
- Branche
- Forskning inden for bioteknologi
- Virksomhedsstørrelse
- 11-50 medarbejdere
- Hovedkvarter
- Copenhagen
- Type
- Nonprofit
- Grundlagt
- 2014
Beliggenheder
-
Primær
Copenhagen, DK
Medarbejdere hos Aging Research & Drug Discovery Meeting
Opdateringer
-
Aging Research & Drug Discovery Meeting genopslog dette
Each year, Aging Research & Drug Discovery Meeting hosts top-class thought leaders and participants from organizations and universities around the world. The last week of August in Copenhagen is the time and place to be to discuss the problems of our aging population and new advancements in longevity. We are happy to see our portfolio companies Ani Biome, Turn Biotechnologies, Rubedo Life Sciences, and Haut.AI among the sponsors and speakers of the event. We are also happy to share that our general partner, Garri Zmudze, will be judging this year’s startup pitch together with Katerina Stroponiati from Brilliant Minds, Jens Nielsen from BioInnovation Institute and with Jitka Kolářová, Lead for Innovations in Health and Healthcare at World Economic Forum, as a moderator. For more information, visit the ARDD website here: https://lnkd.in/dmRE-qJv See you in Copenhagen!
-
📣 Registration Closed for the 11th Aging Research & Drug Discovery Meeting! Thank you to everyone who registered! General registration for #ARDD2024 on site ticket is now officially closed ahead of the originally scheduled time due to its overwhelming popularity. We have reserved 20 tickets for late registration, exclusively for investors, media, and pharmaceutical companies performing aging research, as this will bring additional value to startups and academics. Get ready for #ARDD2024, where we’ve curated an incredible program : -Main Track -Longevity Medicine Track -XPRIZE Healthspan Team Summit -Emerging Science & Technologies Workshop -Physics in Aging Biology Workshop -VC Panel -Pharma Panel -Startup Pitch Session ✨ Special thanks to our amazing sponsors for their generous support! ✨ 🎟️ Late Registration: Don’t miss out! Email [email protected] to secure one of the remaining tickets now Join us for an unforgettable experience on August 26-30, 2024! Daniela Bakula Evelyne Bischof, MD, PhD Alex Zhavoronkov Morten Scheibye-Knudsen Maximilian Unfried
-
-
ARDD is proud to have ACCELERATED BIOSCIENCES CORP. as a Tier 3 sponsor! In the fourth episode of the "Interviews with #ARDD2024 Sponsors" series (link below), Yuta Lee, the CEO of ACCELERATED BIOSCIENCES CORP. talks with Dominika Wilczok about: 🔴Accelerated Biosciences' unique platform and approach to longevity 🔴Yuta's personal motivation for entering the longevity field 🔴Accelerated Biosciences' current research with NIA 🔴 What are Accelerated Bioscianes’s expectations of ARDD? 🔴 Accelerated Biosciences' near-term goals 🔴Yuta’s tips for longevity entrepreneurs Exactly one month is left till #ARDD! https://lnkd.in/dtDJNurz
-
-
ARDD is proud to have HealthyLongevity.clinic as a Tier 3 sponsor! In the third episode of the "Interviews with #ARDD2024 Sponsors" series (link in the comments), the CEO Petr Sramek talks with Dominika Wilczok about: 🔴Healthy Longevity Clinic's overview 🔴Longevity medicine principles and the Healthy Longevity Cafe concept 🔴Motivation for ARDD sponsorship and value of the conference 🔴ARDD's environment and collaboration opportunities 🔴Story behind the success of Healthy Longevity Clinic 🔴Petr’s desired collaborations and investment opportunities Only a month and 1 day left for #ARDD!
-
-
This year, ARDD is proud to have TruDiagnostic as a Tier 3 sponsor. In the second episode of the "Interviews with ARDD2024 sponsors" series (link in the comments), Hannah Went, the co-founder at TruDiagnostic, talks with Dominika Wilczok about: 🔴What is TruDiagnostic 🔴Sneak peek of TruDiagnostic lecture at ARDD24 by Ryan Smith 🔴What kind of partnerships/people is TruDiagnostics looking for? Opportunities for researchers, investors, and students at #ARDD24 🔴Bridging the gap between research and clinical application. 🔴Upcoming milestones for TruDiagnostics Register now to attend the conference at www.agingpharma.org
-
-
Aging Research & Drug Discovery Meeting genopslog dette
My Friends in Aging Research and Fibrotic Diseases, should have a look at this paper (! Link in Comments) and also at the lecture from 9th ARDD in 2022 (!! Link in Comments) by Stuart Cook, Anissa Widjaja and colleagues. It is a very neat work which requires a deeper dive by the many pharma companies and is certainly celebrated by Boehringer Ingelheim, which has the anti-IL-11 antibody for fibrotic diseases (they seem to have missed out on TNIK inhibitors like everyone else but did well in IL11). But the main point of this post is that frontier research in drug discovery and aging research is usually presented at ARDD years before general public sees it in top peer-reviewed journals. This year's ARDD will bring many pharma companies and startups together with top academics. And even my team is preparing something very special and unpublished for presentation. Kudos to Morten Scheibye-Knudsen Daniela Bakula of the Københavns Universitet - University of Copenhagen for their hard volunteer work (it takes 56 weeks to put one ARDD together with weekly calls and coordination of a big team - more than a year as the prep for the next one starts 56 weeks prior). And Evelyne Bischof, MD, PhD, who chairs the Longevity Medicine track. This year, Healthspan XPRIZE headed by Jamie Justice, Ph.D. greatly expanded the ARDD with the introduction of the annual summit and presentations of clinical trial milestones. Editors of major journals are usually on-site to spot these frontier research groups including Sebastien Thuault Marie-Therese Heemels Michael Basson Lisa Melton and many others. Plus, top industry media. If you have other great stories where early research was presented at ARDD and published in top peer-reviewed journal - please share it with #ARDD2024 hashtag.
-
-
-
-
-
5
-
-
We are excited to announce Iuventase Biosciences as a Tier 4 Sponsor of the 11th Aging Research & Drug Discovery Meeting. Iuventase Biosciences is a pioneering longevity company dedicated to extending healthy lifespans. The company provides critical insights into the aging process and age-related diseases by developing a cutting-edge epigenetic biomarker platform. Its primary focus is on creating effective anti-aging interventions, with a significant emphasis on chemical reprogramming drugs that have the potential to revolutionize the field. Committed to pushing the boundaries of healthy aging, Iuventase Biosciences strives to enhance the quality of life and advance the science of aging. #ARDD2024 will feature a dynamic mix of academic institutions, clinicians, industry leaders, and pharmaceutical companies, fostering rich dialogues and unveiling new research in the field of aging. Mark your calendars for August 26-30, 2024 and register now at agingpharma.org https://lnkd.in/gM_MTk7q #ARDD2024 #DrugDiscovery #AgingResearch
Announcing Iuventase Biosciences as Tier 4 Sponsor of ARDD 2024
eurekalert.org
-
We are excited to announce Rubedo Life Sciences as a Tier 5 Sponsor of the 11th Aging Research & Drug Discovery Meeting. Rubedo develops disease-modifying interventions for chronic inflammatory and fibrotic diseases by targeting the underlying biological drivers of chronic diseases of aging, addressing conditions with unmet medical needs. Rethinking cellular senescence: Rubedo therapies are based on targeting specific subtypes of inflammatory or fibrotic senescent cells using a portfolio of selective new small molecules (senolytics 2.0) developed with a proprietary discovery platform that combines AI single cell multiomics and novel chemistry. Rubedo therapeutic pipeline includes a dermatology program advancing to first in human clinical studies and an interstitial lung disease program in preclinical stage. #ARDD2024 will feature a dynamic mix of academic institutions, clinicians, industry leaders, and pharmaceutical companies, fostering rich dialogues and unveiling new research in the field of aging. Mark your calendars for August 26-30, 2024 and register now at agingpharma.org https://lnkd.in/gECusrdH #ARDD2024 #DrugDiscovery #AgingResearch
Announcing Rubedo as Tier 5 Sponsor of ARDD 2024
eurekalert.org
-
Join us for talks on how first-principal physics thinking can help us to better understand aging biology, and dive into dynamic, collaborative whiteboard sessions where we'll brainstorm and explore innovative modeling approaches of the aging process. Maximilian Unfried Uri Alon Albert-Laszlo Barabasi Joshua Johnson, Ph.D. Omer Karin Andrew Rutenberg Mogens Høgh Jensen Jan Gruber Register now at agingpharam.org! #ARDD2024
-